Allosteric inhibition of trypanosomatid pyruvate kinases by a camelid single-domain antibody

African trypanosomes are the causative agents of neglected tropical diseases affecting both humans and livestock. Disease control is highly challenging due to an increasing number of drug treatment failures. African trypanosomes are extracellular, blood-borne parasites that mainly rely on glycolysis for their energy metabolism within the mammalian host. Trypanosomal glycolytic enzymes are therefore of interest for the development of trypanocidal drugs. Here, we report the serendipitous discovery of a camelid single-domain antibody (sdAb aka Nanobody) that selectively inhibits the enzymatic activity of trypanosomatid (but not host) pyruvate kinases through an allosteric mechanism. By combining enzyme kinetics, biophysics, structural biology, and transgenic parasite survival assays, we provide a proof-of-principle that the sdAb-mediated enzyme inhibition negatively impacts parasite fitness and growth.

Authors

Institutions

Publication Details

Journal
eLife
Published
2024-08-21
DOI
https://doi.org/10.7554/elife.100066
Citations
2
Primary Topic
Trypanosoma species research and implications
Type
article
Field-Weighted Citation Impact
0.77

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Allosteric inhibition of trypanosomatid pyruvate kinases by a camelid single-domain antibody

Joar Esteban Pinto Torres, Pieter Van Wielendaele, Aysima Hacisuleyman, Paul A.M. Michels et al.
2 citations
eLife
Trypanosoma species research and implications
0.77
article

Allosteric inhibition of trypanosomatid pyruvate kinases by a camelid single-domain antibody

Joar Esteban Pinto Torres, Pieter Van Wielendaele, Aysima Hacisuleyman, Paul A.M. Michels, Malcolm D. Walkinshaw, Serge Muyldermans, Rik Hendrickx, Meng Yuan, Hans De Winter, Yann G.‐J. Sterckx, Wim Versées, Natalia Smiejkowska, Guy Caljon, Mathieu Claes, Stefan Magez
article en
2 citations

Abstract

African trypanosomes are the causative agents of neglected tropical diseases affecting both humans and livestock. Disease control is highly challenging due to an increasing number of drug treatment failures. African trypanosomes are extracellular, blood-borne parasites that mainly rely on glycolysis for their energy metabolism within the mammalian host. Trypanosomal glycolytic enzymes are therefore of interest for the development of trypanocidal drugs. Here, we report the serendipitous discovery of a camelid single-domain antibody (sdAb aka Nanobody) that selectively inhibits the enzymatic activity of trypanosomatid (but not host) pyruvate kinases through an allosteric mechanism. By combining enzyme kinetics, biophysics, structural biology, and transgenic parasite survival assays, we provide a proof-of-principle that the sdAb-mediated enzyme inhibition negatively impacts parasite fitness and growth.

eLifeVol. 13
Vrije Universiteit Brussel (BE), University of Antwerp (BE), Ghent University (BE), Ghent University Global Campus (KR), VIB-VUB Center for Structural Biology (BE), University of Lausanne (CH), University of Edinburgh (GB)
Fonds Wetenschappelijk Onderzoek, Universiteit Gent, Vrije Universiteit Brussel, Universiteit Antwerpen, Vlaamse regering
Good health and well-being
Openalex Percentile: Top 26%
Trypanosoma species research and implications
0.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.